Literature DB >> 9728563

Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci.

C R MacKenzie1, U Hadding, W Däubener.   

Abstract

Neonatal sepsis is most often caused by group B streptococci (GBS) and is a major cause of death in the neonatal period. The response of the immune system in the newborn child has received much attention and is thought to be deficient in a number of ways. The effector response of neonatal monocyte-derived macrophages (MDM) was investigated. Interferon-gamma induced the activation of indoleamine 2,3-dioxygenase in MDM and inhibited the growth of GBS. Both effects were enhanced by the addition of tumor necrosis factor-alpha to the culture conditions. The coincident supplementation of L-tryptophan with the bacteria abrogated the bacterial growth inhibition, thus confirming the causative role of L-tryptophan depletion. Control of the extracellular as well as intracellular L-tryptophan levels may thus be one of the effector mechanisms with which the immune system defends the host against GBS dissemination and disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9728563     DOI: 10.1086/515347

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.

Authors:  W Däubener; B Spors; C Hucke; R Adam; M Stins; K S Kim; H Schroten
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.

Authors:  Julia Diegelmann; Torsten Olszak; Burkhard Göke; Richard S Blumberg; Stephan Brand
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 3.  Revisiting the host as a growth medium.

Authors:  Stacie A Brown; Kelli L Palmer; Marvin Whiteley
Journal:  Nat Rev Microbiol       Date:  2008-09       Impact factor: 60.633

Review 4.  Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria.

Authors:  Anthony R Richardson; Greg A Somerville; Abraham L Sonenshein
Journal:  Microbiol Spectr       Date:  2015-06

5.  Indoleamine 2,3-dioxygenase, tryptophan catabolism, and Mycobacterium avium subsp. paratuberculosis: a model for chronic mycobacterial infections.

Authors:  Karren M Plain; Kumudika de Silva; John Earl; Douglas J Begg; Auriol C Purdie; Richard J Whittington
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

6.  Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.

Authors:  M J Donovan; V Tripathi; M A Favila; N S Geraci; M C Lange; W Ballhorn; M A McDowell
Journal:  Parasite Immunol       Date:  2012-10       Impact factor: 2.280

7.  Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells.

Authors:  W Däubener; C Hucke; K Seidel; U Hadding; C R MacKenzie
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase.

Authors:  Christian Hucke; Colin R MacKenzie; Koku D Z Adjogble; Osamu Takikawa; Walter Däubener
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.

Authors:  Tomoko Hayashi; Ji-Hun Mo; Xing Gong; Cyprian Rossetto; Angela Jang; Lucinda Beck; Gregory I Elliott; Irina Kufareva; Ruben Abagyan; David H Broide; Jongdae Lee; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.